Tuesday, November 12, 2019
- 9:00AM-11:00AM
-
Abstract Number: 2533
Hydroxychloroquine Increases Low C3 in SLE
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2517
Hydroxychloroquine Is a Modifiable Predictor of Durable LLDAS
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2573
Hydroxychloroquine Levels in Patients with Systemic Lupus Erythematosus: Comparison of Whole Blood and Serum Levels
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 1929
Identification and Validation of Transcriptional Genes Associated with Osteoporotic Vertebral Fractures by Microarray Study, in Community Elderly Women
Genetics, Genomics & Proteomics Poster- 9:00AM-11:00AM
-
Abstract Number: 2487
Identification of Circulating MicroRNA Signatures in Patients with Psoriasis and Psoriatic Arthritis to Develop Novel Strategies for Early Diagnosis of a Bone and Joint Involvement
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 1972
Identification of Distinct Lipidomic Profiles in Synovial Membranes from Inflammatory Arthritis by Mass Spectrometry Imaging
Osteoarthritis & Joint Biology – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 2034
Identification of IL-17+ and IL-10+ TCRαβ+ CD4- CD8- Double Negative (DN) T Cell Subsets in Lupus-prone Mice and Patients with SLE and Their Significance in Predicting Renal Involvement
SLE – Etiology & Pathogenesis Poster II- 9:00AM-11:00AM
-
Abstract Number: 1928
Identification of Immunological Processes Associated with the Response to Abatacept in Rheumatoid Arthritis Using Longitudinal Blood RNA-seq Analysis
Genetics, Genomics & Proteomics Poster- 9:00AM-11:00AM
-
Abstract Number: 2535
Identifying Subgroups of SLE Patients with Differential Responses to a BLyS Inhibitor: Application of a Machine Learning Algorithm to Clinical Trial Data
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2568
Iguratimod Is an Alternative Option for Refractory Lupus Nephritis: A Preliminary Observational Study
SLE – Clinical Poster III: Treatment- 9:00AM-11:00AM
-
Abstract Number: 2493
IL-6 and TNF-α Influence on Clinical Manifestations, Activity and Comorbidity in Psoriatic Arthritis Patients
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features- 9:00AM-11:00AM
-
Abstract Number: 2119
Impact of Day of Admission and Time to Diagnostic Arthrocentesis on Mortality and Other Outcomes in Septic Arthritis: A Nationwide Analysis
Infection-Related Rheumatic Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 2079
Impact of Eliminating the Bouted Minutes Requirement in the New 2018 Physical Activity Guidelines for Americans on Gender Disparity in Guideline Attainment for Persons with or at High Risk of Knee Osteoarthritis
Epidemiology & Public Health Poster III: OA, Gout, & Other Diseases – ARP- 9:00AM-11:00AM
-
Abstract Number: 2455
Impact of Enthesitis on Patient Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey